About Kenvue Inc
- Industry: Consumer products
- Exchange: NEW YORK STOCK EXCHANGE, INC.
- Country: US
- Website: https://www.kenvue.com
Frequently Asked Questions
What is the 52-week range for KVUE?
The 52-week high is $20.13 and the 52-week low is $14.02.
What is the P/E ratio for KVUE?
The Price to Earnings (P/E) ratio is 19.93.
What is the dividend yield for KVUE?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 15.58%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 10.76%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 3.06.
Analyst Recommendation Trends
Wall Street analyst consensus for KVUE over the last few months:
Latest KVUE News
Why Medtronic’s $4 Billion MiniMed Exchange Offer Is Losing Its Allure
The tax-free exchange offer allows Medtronic investors to swap their shares for MiniMed shares held by Medtronic in what Wall Street calls a split-off.
Kenvue (KVUE) Stock Still Appears 41% Undervalued On Cash Flow
Kenvue has delivered a 16.1% gain over the past year, even as shorter term returns have been softer. This puts fresh focus on whether the current share price lines up with the cash the business can generate over time. With the stock last closing at US$17.22, the question for investors is how much of Kenvue’s future cash flows are already reflected in that tag. The 16.1% return over the past 12 months puts recent buyers in profit and raises the issue of whether that move is fully supported by...
Kimberly-Clark Announces Planned Executive Transitions and Updates to Post-Closing Leadership Team
Kimberly-Clark Corporation (NASDAQ: KMB) today announced planned executive transitions and updates to the future leadership team for the company upon completion of its pending acquisition of Kenvue Inc. (NYSE: KVUE), which is expected in the fourth quarter of 2026.
LISTERINE® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 Billion
SUMMIT, N.J., October 01, 2026--Nearly half the world’s population is affected by oral disease – and the number of cases is rising. This World Smile Day, LISTERINE® is launching Oral Care Counts – a multiyear education and advocacy initiative showing why oral health is an essential part of overall health and how practical daily habits, including a three-step oral care routine of brushing, flossing and rinsing, can support better oral health. The multiyear education and advocacy campaign is desig
Kimberly Clark (KMB) Stock Could Be A Bargain After A 16% Slide
Kimberly-Clark has had a rough stretch in the market over the past year, and that weak share performance puts fresh focus on one core issue: whether the current price around US$97 is sensible when you line it up against the cash the business is expected to generate. With investors also watching the pending Kenvue acquisition and related financing steps, the key question now is how those moves feed into the long term cash flow story behind the stock. The share price has fallen 16.5% over the...
Kimberly Clark (KMB) Launches Exchange Offers For Outstanding Notes
Kimberly-Clark (NasdaqGS:KMB) has launched exchange offers and consent solicitations for Kenvue's outstanding notes tied to its pending acquisition. The proposal gives Kenvue bondholders the option to swap existing securities into new Kimberly-Clark issued notes subject to specified terms. The consent solicitations seek bondholder approval to amend certain covenants in Kenvue's current debt documents as part of the transaction process. Kimberly-Clark's move to exchange and amend Kenvue notes...
Kimberly-Clark Keeps Raising Its Dividend. The Question Is Whether It Is Keeping Up With Your Costs
Kimberly-Clark just logged its 54th straight year of dividend increases, but a shrinking raise, falling free cash flow, and a massive acquisition in progress raise a pointed question for income investors living on those checks.
5 ‘Bulletproof’ Dividend Kings Boomers Should Buy Now Before the Market Shifts
Rising rates have boomers flocking to Treasuries, but five battle-tested dividend payers with 50-plus years of consecutive increases may offer something bonds simply cannot deliver.
Neutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair
VIENNA, September 30, 2026--Neutrogena®, Aveeno®, and Regaine®* will present 12 new scientific data sets at the 35th European Academy of Dermatology and Venereology (EADV) Congress taking place September 30th through October 3rd in Vienna.
Kimberly-Clark Pays Out Almost Everything It Earns. Can the Dividend Survive the Kenvue Deal?
Kimberly-Clark (NASDAQ:KMB) pays a quarterly dividend of $1.28 per share. That is an annualized forward rate of $5.12 and a yield of 5.16%. The problem sits right next to it. Trailing diluted EPS is $5.08, and the company overview lists dividend per share at the same $5.08. Kimberly-Clark is paying out essentially everything it makes […]
Kimberly-Clark Corporation Announces Commencement of Exchange Offers and Consent Solicitations for Kenvue Notes
Kimberly-Clark Corporation (NASDAQ: KMB) ("Kimberly-Clark") announced today the commencement, in connection with its previously announced pending acquisition ("Acquisition") of Kenvue Inc. (NYSE: KVUE) ("Kenvue"), of an exchange offer (each an "Exchange Offer" and, collectively, the "Exchange Offers") for any and all outstanding notes (the "Kenvue Notes") issued by Kenvue for up to $7,000,000,000 aggregate principal amount of new notes to be issued by Kimberly-Clark (the "Kimberly-Clark Notes")
PG vs. KMB: Bigger Yield Isn’t Everything. Here’s Which Stock Truly Delivers for Retirees
Kimberly-Clark hands retirees a fatter dividend check every quarter, but one look at what sits behind that payout changes the picture fast. Before you choose the bigger yield, consider what happens when the income has to last decades.
Beyond Revenue Growth: Unpacking The Drivers Of Consumer Products Growth
Visible Alpha consensus estimates for CY2026 show a wide dispersion in expected growth across the household and personal products peer group.
Kimberly-Clark’s 54-Year Dividend Streak Masks a Troubling Cash Flow Problem
Kimberly-Clark just logged 54 straight years of dividend raises, but a closer look at the cash flow statement raises an uncomfortable question about who is actually funding that growing payout.
5 Beaten-Down Dividend Kings Ready to Roar Back in 2027 (One Yields Over 5%)
While investors pile into pricey AI darlings, a handful of battle-tested Dividend Kings have quietly slipped to levels that scream value, and Wall Street analysts see serious upside ahead for 2027.
Kenvue Inc's Dividend Analysis
This article first appeared on GuruFocus. Kenvue Inc (NYSE:KVUE) recently announced a total dividend of $0.21 per share, with the ex-dividend date set for 2026-09-21. For income-focused investors, the ex-dividend date is a critical marker: shareholders must own the stock before this date to qualify for the payment.
Kimberly Clark (KMB) Lines Up Assets for $40 Billion Deal Review
Kimberly-Clark (NasdaqGS:KMB) plans to sell assets tied to its planned US$40b acquisition of consumer products group Kenvue. The disposals are aimed at addressing European Union antitrust concerns linked to overlaps in consumer health and personal care brands. Asset sale discussions focus on EU markets where regulators flagged competition issues as part of their ongoing review of the Kenvue deal. Kimberly-Clark's move to sell assets around the US$40b Kenvue deal sits within a broader pattern...
The Moneymaxxing Crowd Will Love 5 High-Yield Dividend Stocks Under $20
Younger investors are rewriting the rules of wealth building, and five overlooked dividend stocks under $20 sit right at the center of that shift. The real question is whether these picks can hold up long enough to matter.
Better Dividend King to Buy and Hold: Johnson & Johnson or Kenvue?
One healthcare dividend payer carries legal risk, the other faces a buyout. Here's which one actually deserves your money.
Kimberly-Clark May Sell Assets to Save Its $40 Billion Kenvue Deal: Report
Kimberly-Clark prepares EU concessions to win approval for its $40B Kenvue deal, following Australian divestiture demands.
Explore the S&P500 index on Tuesday and find out which stocks are the most active in today's session.
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Tuesday and uncover the stocks that are leading the way in terms of trading volume and market attention.
Should Kenvue’s (KVUE) TYLENOL with Naproxen Launch and Dividend Plan Prompt Investor Reassessment?
Kenvue Inc. previously announced that its Board of Directors declared a quarterly dividend of US$0.21 per share, payable on October 2, 2026, to shareholders of record as of September 21, 2026, while also securing FDA approval for TYLENOL with Naproxen, a first-of-its-kind non-opioid OTC pain reliever backed by multiple clinical studies. By pairing a new, clinically supported TYLENOL with Naproxen launch with ongoing cash returns via dividends, Kenvue is highlighting both product innovation...
Is Kenvue (KVUE) A Bargain Following Its TYLENOL With Naproxen Launch?
Kenvue (KVUE) is on investors’ radar after launching TYLENOL with Naproxen, an FDA-approved, opioid-free over the counter pain reliever that combines acetaminophen and naproxen sodium, backed by extensive clinical research. That launch comes as Kenvue’s share price has softened in the short term, with a 7 day share price return of down 4.43% and a 30 day share price return of down 6.72%. Even though the year to date share price return is 3.41% and the 1 year total shareholder return is 2.85%,...
Kimberly-Clark Moves to Clear EU Hurdle with Kenvue Asset Sales
Kimberly-Clark Corporation (NASDAQ:KMB) is preparing asset sales to address EU antitrust concerns surrounding its planned $40 billion acquisition of Kenvue, according to Reuters. The company is reportedly seeking to offer remedies that could secure European Commission approval by the September 29 deadline, avoiding a more extensive four-month investigation. Similar regulatory concerns have already emerged in […]
Sector Update: Consumer Stocks Mixed Late Afternoon
Consumer stocks were mixed late Monday afternoon, with the State Street Consumer Staples Select Sect
These S&P500 stocks are the most active in today's session
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Monday. Discover the stocks that are generating the highest trading volume and driving market activity.
Here's My Pick for the Smartest High-Yield Dividend Stock to Buy Right Now
Kenvue's dependable dividend is above average, and it could go even higher if the company is bought by Kimberly-Clark.
Who Buys Colgate’s Cast-Off Brands? Why the Obvious Answers Are Unlikely.
Colgate is reportedly shopping Softsoap, Irish Spring, and Speed Stick with Goldman Sachs running the process, but the names most investors would expect to step up all have reasons to sit this one out.
Sorbent to acquire Kenvue's Stayfree and Carefree business in Australia and New Zealand
Sorbent Paper Company Pty Ltd ("Sorbent") has signed an agreement with Kenvue's Singaporean subsidiary to acquire its Stayfree and Carefree feminine care business in Australia and New Zealand. Following completion of the transaction, the business in New Zealand will be managed by Sorbent's affiliate, Cottonsoft.
Is Kenvue Underperforming the Nasdaq?
Kenvue stock has lagged the broader market over the past year, although analysts remain neutral on the company’s future prospects.
Kimberly-Clark’s 54-Year Dividend Streak Faces Its Biggest Test Yet With $48.7 Billion Kenvue Deal
Kimberly-Clark just raised its dividend for the 54th straight year while simultaneously chasing a nearly $50 billion acquisition, and income investors are now weighing whether a deal of that size can coexist with a payout that costs over $1.6 billion annually.
Curious about the most active S&P500 stocks in today's session?
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.
In today's session, there are S&P500 stocks with remarkable trading volume.
Let's have a look at the S&P500 stocks with an unusual volume in today's session.
Kenvue Declares Quarterly Cash Dividend
SUMMIT, N.J., September 10, 2026--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.21 per share on its common stock. The quarterly dividend is payable on October 2, 2026, to shareholders of record as of the close of business on September 21, 2026.
Reported September 8, 2026: 'Tylenol Use In Pregnancy May Be Linked With Uterus, Ovary Changes In Daughters' - Reuters News
https://www.reuters.com/business/healthcare-pharmaceuticals/tylenol-use-pregnancy-may-be-linked-with-uterus-ovary-changes-daughters-2026-09-09/
Kenvue's Brand Strength and Innovation Strategy Support Growth
KVUE's trusted brands, innovation and productivity initiatives support growth as it strengthens its consumer health portfolio and global reach.
American Century Value Fund Q2 2026 Contributors And Detractors
Key contributors include Infineon Technologies, Teradyne and Walmart. Learn more about key detractors.
Can Kimberly-Clark Turn its $40 Billion Kenvue Bet into $2.1 Billion in Savings?
Kimberly-Clark Corporation’s (NASDAQ:KMB) proposed $40 billion takeover of Kenvue has entered another stage of regulatory review. Documents on the European Commission’s website show that Kimberly-Clark has requested EU permission to complete the transaction, which was first announced in November 2025. The deal would combine Kimberly-Clark (NASDAQ:KMB) with a large portfolio of consumer-health brands, including Tylenol, […]
Kenvue's Kimberly-Clark Deal Nears Closing With Key Risks Still Ahead
KVUE nears its planned combination after shareholder and U.S. antitrust clearances, while margin, debt and legal risks temper the Q4 2026 outlook.
Should Investors Buy KVUE as Margin Gains Offset Slow Sales Growth?
Kenvue's profit margins and cash flow improved in the first half, but modest sales growth, debt and uneven segment trends keep the risk-reward balanced.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-28 | ALLISON RICHARD E JR | +1,300 | - | - |
| 2026-09-28 | Smith Jeffrey C | +1,300 | - | - |
| 2026-09-25 | Stevens Meredith | -1,032 | - | - |
| 2026-09-25 | Stevens Meredith | -429 | - | - |
| 2026-09-25 | Stevens Meredith | -1,032 | $17.81 | $18,380 |
| 2026-09-25 | Stevens Meredith | +1,032 | - | - |
| 2026-09-25 | Stevens Meredith | -429 | $17.81 | $7,640 |
| 2026-09-25 | Stevens Meredith | +429 | - | - |
| 2026-07-31 | Dasgupta Anindya | -16,419 | - | - |
| 2026-07-31 | Dasgupta Anindya | +16,419 | - | - |
| 2026-06-29 | ALLISON RICHARD E JR | +1,413 | - | - |
| 2026-06-29 | Smith Jeffrey C | +1,413 | - | - |
| 2026-06-10 | Howlett Heather | -3,700 | $18.105 | $66,989 |
| 2026-05-21 | Mann Erica L | +10,309 | $17.46 | $179,995 |
| 2026-05-21 | Godbole Seemantini | +10,309 | $17.46 | $179,995 |
| 2026-05-21 | Hofstetter Sarah | +10,309 | $17.46 | $179,995 |
| 2026-05-21 | Sneed Michael E | +10,309 | $17.46 | $179,995 |
| 2026-05-21 | PAWLUS KATHLEEN M | +10,309 | $17.46 | $179,995 |
| 2026-05-21 | ALLISON RICHARD E JR | +10,309 | $17.46 | $179,995 |
| 2026-05-21 | Healey Melanie | +10,309 | $17.46 | $179,995 |
| 2026-05-21 | Smith Jeffrey C | +10,309 | $17.46 | $179,995 |
| 2026-05-21 | PRABHU VASANT M | +10,309 | $17.46 | $179,995 |
| 2026-05-21 | MERLO LARRY J | +16,036 | $17.46 | $279,989 |
| 2026-05-21 | HOLDEN BETSY D | +10,309 | $17.46 | $179,995 |
| 2026-05-08 | Orlando Matthew | -38,491 | $17.6583 | $679,686 |
| 2026-05-01 | Curado Gomes de Lemos Leonardo | -24,248 | - | - |
| 2026-05-01 | Curado Gomes de Lemos Leonardo | -7,141 | $17.43 | $124,468 |
| 2026-05-01 | Curado Gomes de Lemos Leonardo | +24,248 | - | - |
| 2026-03-30 | Smith Jeffrey C | +1,331 | - | - |
| 2026-03-30 | ALLISON RICHARD E JR | +1,331 | - | - |
| 2026-03-10 | Stevens Meredith | -840 | - | - |
| 2026-03-10 | Stevens Meredith | -4,329 | - | - |
| 2026-03-10 | Stevens Meredith | -358 | $18.16 | $6,501 |
| 2026-03-10 | Stevens Meredith | +840 | - | - |
| 2026-03-10 | Stevens Meredith | -1,738 | $17.96 | $31,214 |
| 2026-03-10 | Stevens Meredith | +4,329 | - | - |
| 2026-03-10 | Alvarado Luani | -697 | - | - |
| 2026-03-10 | Alvarado Luani | -3,525 | - | - |
| 2026-03-10 | Alvarado Luani | -357 | $18.16 | $6,483 |
| 2026-03-10 | Alvarado Luani | +697 | - | - |
| 2026-03-10 | Alvarado Luani | -1,721 | $17.96 | $30,909 |
| 2026-03-10 | Alvarado Luani | +3,525 | - | - |
| 2026-03-10 | Lawson Carlton | -6,158 | - | - |
| 2026-03-10 | Lawson Carlton | +6,158 | - | - |
| 2026-03-05 | Lawson Carlton | -7,736 | - | - |
| 2026-03-05 | Lawson Carlton | +7,736 | - | - |
| 2026-03-05 | Alvarado Luani | -4,289 | - | - |
| 2026-03-05 | Alvarado Luani | -2,094 | $18.25 | $38,216 |
| 2026-03-05 | Alvarado Luani | +4,289 | - | - |
| 2026-03-05 | Stevens Meredith | -6,178 | - | - |
| 2026-03-05 | Stevens Meredith | -1,677 | $18.25 | $30,605 |
| 2026-03-05 | Stevens Meredith | +6,178 | - | - |
| 2026-03-05 | Howlett Heather | -2,723 | - | - |
| 2026-03-05 | Howlett Heather | -933 | $18.25 | $17,027 |
| 2026-03-05 | Howlett Heather | +2,723 | - | - |
| 2026-03-03 | Howlett Heather | -1,534 | - | - |
| 2026-03-03 | Howlett Heather | -526 | $18.15 | $9,547 |
| 2026-03-03 | Howlett Heather | +1,534 | - | - |
| 2026-03-02 | Orlando Matthew | +122,286 | - | - |
| 2026-03-02 | Curado Gomes de Lemos Leonardo | +13,234 | - | - |
| 2026-03-02 | Dasgupta Anindya | +98,994 | - | - |
| 2026-03-02 | Lawson Carlton | +93,488 | - | - |
| 2026-03-02 | Alvarado Luani | +79,407 | - | - |
| 2026-03-02 | De Jesus Carlos | +127,051 | - | - |
| 2026-03-02 | Tillett Caroline | +63,525 | - | - |
| 2026-03-02 | Stevens Meredith | +92,641 | - | - |
| 2026-03-02 | Halvorson Jonathan | +51,879 | - | - |
| 2026-03-02 | Dyer Russell | +43,673 | - | - |
| 2026-03-02 | Howlett Heather | +22,233 | - | - |
| 2026-03-02 | Wondrasch Michael | +79,407 | - | - |
| 2026-03-02 | Perry Kirk | +491,662 | - | - |
| 2026-02-13 | Stevens Meredith | -3,215 | - | - |
| 2026-02-13 | Stevens Meredith | -24,825 | - | - |
| 2026-02-13 | Stevens Meredith | -884 | $18.66 | $16,495 |
| 2026-02-13 | Stevens Meredith | +3,215 | - | - |
| 2026-02-13 | Stevens Meredith | -7,147 | $18.66 | $133,363 |
| 2026-02-13 | Stevens Meredith | +24,825 | - | - |
| 2026-02-13 | Alvarado Luani | -1,822 | - | - |
| 2026-02-13 | Alvarado Luani | -14,120 | - | - |
| 2026-02-13 | Alvarado Luani | -625 | $18.66 | $11,663 |
| 2026-02-13 | Alvarado Luani | +1,822 | - | - |
| 2026-02-13 | Alvarado Luani | -4,843 | $18.66 | $90,370 |
| 2026-02-13 | Alvarado Luani | +14,120 | - | - |
| 2026-02-13 | Lawson Carlton | -34,907 | - | - |
| 2026-02-13 | Lawson Carlton | -4,519 | - | - |
| 2026-02-13 | Lawson Carlton | +34,907 | $18.66 | $651,365 |
| 2026-02-13 | Lawson Carlton | +4,519 | - | - |
| 2026-02-13 | Howlett Heather | -1,555 | - | - |
| 2026-02-13 | Howlett Heather | -12,016 | - | - |
| 2026-02-13 | Howlett Heather | -518 | $18.66 | $9,666 |
| 2026-02-13 | Howlett Heather | +1,555 | - | - |
| 2026-02-13 | Howlett Heather | -4,131 | $18.66 | $77,084 |
| 2026-02-13 | Howlett Heather | +12,016 | - | - |
| 2026-02-06 | Alvarado Luani | -85,534 | - | - |
| 2026-02-06 | Alvarado Luani | -71,581 | $18.13 | $1,297,764 |
| 2026-02-06 | Alvarado Luani | +85,534 | $13.76 | $1,176,948 |
| 2026-01-02 | Halvorson Jonathan | +34,642 | - | - |
| 2026-01-02 | BANATI AMIT | +144,341 | - | - |
| 2025-12-15 | Perry Kirk | -56,007 | $17.21 | $963,880 |
| 2025-12-15 | De Jesus Carlos | +483,870 | - | - |
| 2025-12-15 | De Jesus Carlos | +50,842 | - | - |
| 2025-12-15 | Dyer Russell | -2,156 | - | - |
| 2025-12-15 | Dyer Russell | -2,752 | - | - |
| 2025-12-15 | Dyer Russell | -1,103 | $17.21 | $18,983 |
| 2025-12-15 | Dyer Russell | +2,156 | - | - |
| 2025-12-15 | Dyer Russell | -1,408 | $17.21 | $24,232 |
| 2025-12-15 | Dyer Russell | +2,752 | - | - |
| 2025-12-15 | Tillett Caroline | -3,372 | - | - |
| 2025-12-15 | Tillett Caroline | -4,399 | - | - |
| 2025-12-15 | Tillett Caroline | -2,994 | - | - |
| 2025-12-15 | Tillett Caroline | -23,158 | - | - |
| 2025-12-15 | Tillett Caroline | -1,725 | $17.21 | $29,687 |
| 2025-12-15 | Tillett Caroline | +3,372 | - | - |
| 2025-12-15 | Tillett Caroline | -2,251 | $17.21 | $38,740 |
| 2025-12-15 | Tillett Caroline | +4,399 | - | - |
| 2025-12-15 | Tillett Caroline | -1,532 | $17.28 | $26,473 |
| 2025-12-15 | Tillett Caroline | +2,994 | - | - |
| 2025-12-15 | Tillett Caroline | -11,846 | $17.28 | $204,699 |
| 2025-12-15 | Tillett Caroline | +23,158 | - | - |
| 2025-12-15 | Orlando Matthew | -5,611 | - | - |
| 2025-12-15 | Orlando Matthew | -6,361 | - | - |
| 2025-12-15 | Orlando Matthew | -1,370 | - | - |
| 2025-12-15 | Orlando Matthew | -10,579 | - | - |
| 2025-12-15 | Orlando Matthew | -3,445 | $17.21 | $59,288 |
| 2025-12-15 | Orlando Matthew | +5,611 | - | - |
| 2025-12-15 | Orlando Matthew | -3,905 | $17.21 | $67,205 |
| 2025-12-15 | Orlando Matthew | +6,361 | - | - |
| 2025-12-15 | Orlando Matthew | -841 | $17.28 | $14,532 |
| 2025-12-15 | Orlando Matthew | +1,370 | - | - |
| 2025-12-15 | Orlando Matthew | -6,494 | $17.28 | $112,216 |
| 2025-12-15 | Orlando Matthew | +10,579 | - | - |
| 2025-12-15 | Perry Kirk | -118,562 | - | - |
| 2025-12-15 | Perry Kirk | -66,614 | $17.21 | $1,146,427 |
| 2025-12-15 | Perry Kirk | +118,562 | - | - |
| 2025-12-12 | Smith Jeffrey C | +3,200,000 | $17.373 | $55,593,600 |
| 2025-12-11 | Smith Jeffrey C | +3,177,694 | $17.4318 | $55,392,926 |
| 2025-12-01 | Orlando Matthew | -4,378 | - | - |
| 2025-12-01 | Orlando Matthew | -2,031 | $17.22 | $34,974 |
| 2025-12-01 | Orlando Matthew | +4,378 | - | - |
| 2025-12-01 | Lawson Carlton | -1,779 | - | - |
| 2025-12-01 | Lawson Carlton | +1,779 | - | - |
| 2025-12-01 | Stevens Meredith | -2,776 | - | - |
| 2025-12-01 | Stevens Meredith | -1,180 | $17.22 | $20,320 |
| 2025-12-01 | Stevens Meredith | +2,776 | - | - |
| 2025-12-01 | Alvarado Luani | -2,021 | - | - |
| 2025-12-01 | Alvarado Luani | -731 | $17.22 | $12,588 |
| 2025-12-01 | Alvarado Luani | +2,021 | - | - |
| 2025-12-01 | Tillett Caroline | -1,539 | - | - |
| 2025-12-01 | Tillett Caroline | -788 | $17.22 | $13,569 |
| 2025-12-01 | Tillett Caroline | +1,539 | - | - |
| 2025-12-01 | Hofstetter Sarah | +1,451 | - | - |
| 2025-12-01 | ALLISON RICHARD E JR | +1,451 | - | - |
| 2025-12-01 | Smith Jeffrey C | +1,451 | - | - |
| 2025-11-18 | Alvarado Luani | -123 | - | - |
| 2025-11-18 | Alvarado Luani | -309 | - | - |
| 2025-11-18 | Alvarado Luani | -123 | $14.37 | $1,768 |
| 2025-11-18 | Alvarado Luani | +123 | - | - |
| 2025-11-18 | Alvarado Luani | -309 | $14.37 | $4,440 |
| 2025-11-18 | Alvarado Luani | +309 | - | - |
| 2025-11-18 | Stevens Meredith | -166 | - | - |
| 2025-11-18 | Stevens Meredith | -494 | - | - |
| 2025-11-18 | Stevens Meredith | -166 | $14.37 | $2,385 |
| 2025-11-18 | Stevens Meredith | +166 | - | - |
| 2025-11-18 | Stevens Meredith | -494 | $14.37 | $7,099 |
| 2025-11-18 | Stevens Meredith | +494 | - | - |
| 2025-10-03 | Howlett Heather | -27,181 | - | - |
| 2025-10-03 | Howlett Heather | -9,633 | $15.78 | $152,009 |
| 2025-10-03 | Howlett Heather | +27,181 | - | - |